abstract |
The present invention relates to compounds having activity as sodium channel (e.g., NaV 1.7) inhibitors useful for treating sodium channel-mediated diseases or conditions, such as pain, as well as other diseases and conditions associated with the mediation of the sodium channel, And methods for using the compounds and compositions. |